Cost-effectiveness of clopidogrel plus aspirin vs. aspirin alone for secondary-prevention of cardiovascular events: Results from the CHARISMA trial

被引：0
|
作者：
Chen, Jersey
Bhatt, Deepak L.
Schneider, Elizabeth
Shi, Chunxue
Caro, Jaime
Proskorovsky, Irina
Hacke, Werner
Fox, Keith A.
Cohen, David J.
机构：
[1] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[2] Cleveland Clin, Cleveland, OH 44106 USA
[3] Harvard Clin Res Inst, Boston, MA USA
[4] Caro Res, Concord, MA USA
[5] Univ Heidelberg, D-6900 Heidelberg, Germany
[6] Univ Edinburgh, Edinburgh EH8 9YL, Midlothian, Scotland
来源：
CIRCULATION | 2006年 / 114卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：826 / 826
页数：1
相关论文
共 50 条
  • [41] COST-EFFECTIVENESS OF PROTON PUMP INHIBITORS FOR PREVENTION OF GASTROINTESTINAL ADVERSE EVENTS WHEN USING ASPIRIN FOR PRIMARY CARDIOVASCULAR PREVENTION
    Earnshaw, S.
    Pignone, M.
    Fendrick, A. M.
    Scheiman, J. M.
    McDade, C.
    VALUE IN HEALTH, 2010, 13 (03) : A166 - A166
  • [42] European cost-effectiveness of oral anticoagulation vs. aspirin after myocardial infarction
    Gianetti, J
    Gensini, GF
    DeCaterina, R
    THROMBOSIS AND HAEMOSTASIS, 1997, : PS332 - PS332
  • [43] RELATIONSHIP BETWEEN BLEEDING AND MORTALITY IN PATIENTS ON DUAL ANTIPLATELET THERAPY VS ASPIRIN ALONE: RESULTS FROM THE CHARISMA TRIAL
    Berger, Jeffrey S.
    Bhatt, Deepak L.
    Steg, Gabriel P.
    Steinhubl, Steven R.
    Montalescot, Gilles
    Shao, Mingyuan
    Hacke, Werner
    Fox, Keith A.
    Berger, Peter B.
    Topol, Eric J.
    Lincoff, Michael
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E1237 - E1237
  • [44] Cost-effectiveness analysis of aspirin for primary prevention of cardiovascular events among patients with type 2 diabetes in China
    Jiang, Minghuan
    Li, Pengchao
    You, Joyce Hoi-sze
    Zheng, Xinglong
    Deng, Jizhao
    Zhao, Mingyue
    Feng, Liuxin
    Fang, Yu
    PLOS ONE, 2019, 14 (12):
  • [45] Aspirin plus clopidogrel versus aspirin alone for the prevention of coronary artery bypass graft occlusion: angiographic and clinical results of a randomized study
    Maria J Dalmau
    Manuel Barreiro
    Javier López-Rodríguez
    Maria Bueno
    Elena Arnáiz
    Adolfo Arévalo
    Ana Martín
    Jose M González-Santos
    Journal of Cardiothoracic Surgery, 10 (Suppl 1)
  • [46] Commentary: Cost-Effectiveness Analysis of Rivaroxaban Plus Aspirin Compared With Aspirin Alone in Patients With Coronary and Peripheral Artery Diseases in Italy
    Rawal, Shalin
    Sharma, Kamal
    Shah, Aditya
    Bavishi, Shriya
    Christian, Cleris
    Bhatt, Parjanya
    Konat, Ashwati
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [47] Cost-effectiveness of clopidogrel versus aspirin in the prevention of ischemic events in stroke and tia patients: A four-European country analysis
    Palmer, AJ
    Roze, S
    Hankey, G
    Hakimi, Z
    Spiesser, J
    Carita, P
    Gabriel, S
    VALUE IN HEALTH, 2005, 8 (03) : 334 - 334
  • [48] After TAVI, aspirin vs. aspirin plus clopidogrel for 3 mo reduced bleeding and a composite of bleeding and thrombotic events at 1 y
    Moreno, Raul
    ANNALS OF INTERNAL MEDICINE, 2021, 174 (02) : JC21 - JC21
  • [49] Cost-effectiveness of aspirin treatment in the primary prevention of cardiovascular disease events in subgroups based on age, gender, and varying cardiovascular risk
    Greving, Jacoba P.
    Buskens, Erik
    Koffijberg, Hendrik
    Algra, Ale
    CIRCULATION, 2008, 117 (22) : 2875 - 2883
  • [50] Cost-Effectiveness of Vonoprazan Compared With Proton Pump Inhibitors in Patients Taking Low-Dose Aspirin for Secondary Prevention of Cardiovascular Events in Japan
    Ishii, Masanobu
    Kawai, Takashi
    Tsujita, Kenichi
    Igarashi, Ataru
    Suzuki, Manabu
    Deguchi, Hisato
    Fernandez, Jovelle
    CIRCULATION JOURNAL, 2023, 87 (02) : 348 - 359
12345